CHRISTOPHER SCHENEWERK: Open Payments
NPI 1154328722 · SMITHTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 51 payments from 19 companies in 2025. Trend: 2023 $14,491 · 2024 $6,623 · 2025 $1,107
Food & beverage: $905Education: $202
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $197 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| ABBVIE INC. | 9 | $144 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| PFIZER INC. | 3 | $59 |
| Amgen Inc. | 3 | $59 |
| Novo Nordisk Inc | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
Products named: REXULTI, FARXIGA, OTEZLA, VRAYLAR, SPRAVATO, CAPLYTA, MOUNJARO, FANAPT.
Industry payments across IL — which companies pay providers there.
